Keros Therapeutics, Inc. (KROS) shares soared 5.1% in the last trading session to close at $11.41. The move was backed by solid volume with far more shares changing hands than in a normal session.
A downtrend has been apparent in Keros Therapeutics, Inc. (KROS) lately with too much selling pressure. The stock has declined 36.2% over the past four weeks. However, given the fact that it is ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Keros Therapeutics (NASDAQ:KROS) traded higher on Tuesday after the company announced that its previously announced licensing agreement with Takeda (TAK) for its lead asset elritercept took effect ...
View Our Latest Analysis on KROS Keros Therapeutics Stock Down 3.4 % Shares of NASDAQ:KROS opened at $10.49 on Monday. Keros Therapeutics has a 52-week low of $9.77 and a 52-week high of $73.00 ...
Nasdaq Surges Over 2%; Goldman Sachs Posts Upbeat Q4 Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results